TNDM Tandem Diabetes Care, Inc.
Healthcare$14.54-2.84%ClosedMarket Cap: $996.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
7.51
P/S
0.97
EV/EBITDA
-20.53
DCF Value
$-47.25
FCF Yield
-0.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
54.9%
Operating Margin
-7.9%
Net Margin
-9.2%
ROE
-68.3%
ROA
-8.2%
ROIC
-8.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $247.2M | 55.3% | $-17.4M | $-20.4M | $— | — |
| Q4 null | $290.4M | 57.7% | $8.3M | $-589.0K | $— | — |
| FY null | $1.01B | 52.3% | $-78.1M | $-204.7M | $— | — |
| Q3 null | $249.3M | 53.9% | $-20.1M | $-21.2M | $— | — |
| Q2 null | $240.7M | 52.3% | $-51.8M | $-52.4M | $— | — |
| Q1 null | $234.4M | 50.5% | $-120.9M | $-130.6M | $— | — |
| Q4 null | $282.6M | 55.7% | $-582.0K | $755.0K | $— | — |
| FY null | $940.2M | 52.1% | $-99.1M | $-96.0M | $— | — |
| Q3 null | $363.3M | 34.3% | $-26.1M | $-23.3M | $— | — |
| Q2 null | $221.9M | 50.8% | $-30.8M | $-30.8M | $— | — |
| Q1 null | $191.7M | 49.4% | $-41.7M | $-42.7M | $— | — |
| Q4 2023 | $196.8M | 47.4% | $-35.1M | $-30.0M | $-0.46 | — |